🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 95 of 200 · A–Z by INN

  1. imipramine

    IMIPRAMINE (LEADING) Amdipharm Mercury (Australia) Pty Limited

    TGA: approved

  2. imipramine hydrochloride

    IMIPRAMINE HYDROCHLORIDE Teva Pharma GmbH

    INJECTION FDA: approved

  3. imipramine pamoate

    IMIPRAMINE PAMOATE

    ORAL FDA: approved

  4. imiquimod

    ALDARA Lacuna Pharma Pty Ltd

    TOPICAL FDA: approved · EMA: approved · TGA: approved

    D06BB10

  5. imlifidase

    IDEFIRIX

    EMA: approved

    L04AA

  6. imlunestrant

    INLURIYO

    EMA: approved

    L02BA

  7. imlunestrant tosylate

    INLURIYO

    ORAL FDA: approved

  8. imm01

    NMPA: clinical trials

  9. imm2520

    NMPA: clinical trials

  10. immunocheckpoint

    NMPA: clinical trials

  11. immunochemotherapy

    NMPA: clinical trials

  12. immunomodulatory

    NMPA: clinical trials

  13. immunotherapy

    NMPA: clinical trials

  14. imp4297

    NMPA: clinical trials

  15. in10018

    NMPA: clinical trials

  16. inactivated

    NMPA: clinical trials

  17. inamrinone lactate

    INOCOR

    INJECTION FDA: approved

  18. inavolisib

    ITOVEBI

    ORAL FDA: approved · EMA: approved

  19. inclisiran

    LEQVIO Novartis Pharmaceuticals

    EMA: approved · TGA: approved

    C10AX

  20. inclisiran sodium

    LEQVIO

    SUBCUTANEOUS FDA: approved

  21. incobotulinumtoxina

    XEOMIN Lacuna Pharma Pty Ltd

    INJECTION FDA: approved · TGA: approved

  22. indacaterol

    ONBREZ Novartis Pharmaceuticals

    EMA: approved · TGA: approved

    R03AK

  23. indacaterol + glycopyrronium

    ULTIBRO BREEZHALER 110/50 Novartis Pharmaceuticals

    TGA: approved

  24. indacaterol + glycopyrronium + mometasone

    ENERZAIR BREEZHALER Novartis Pharmaceuticals

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources